Article
Endocrinology & Metabolism
Yue Dong, Zhenyuan Chen, Yanhong Gong, Yanping Han, Hanbing Yu, Xiaozhou Zeng, Zimei Chen, Rongrong An, Na Sun, Xiaoxv Yin
Summary: The study found that weight changes over 18 months among patients with type 2 diabetes, especially weight change >= 5%, may be a warning sign of adverse cardiovascular outcomes.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2022)
Article
Geriatrics & Gerontology
Kristen DeCarlo, Amisha Wallia, Raymond H. Kang, Andrew Cooper, Manisha Cherupally, Sterling A. Harris, Cassandra Aikman, David T. Liss, Ronald T. Ackermann, Matthew J. O'Brien
Summary: Despite clinical consensus to use caution in prescribing certain antidiabetic medications among older adults in poor health, these medications remain commonly used in this population.
Review
Endocrinology & Metabolism
Arthur H. Owora, David B. Allison, Xuan Zhang, Nana Gletsu-Miller, Kishore M. Gadde
Summary: The risk of type 2 diabetes among individuals with overweight or obesity is affected by the temporal dynamics of weight change and specific trajectory groups.
CURRENT DIABETES REPORTS
(2022)
Article
Medicine, Research & Experimental
Monica Frazer, Caroline Swift, Noelle N. Gronroos, Andrew Sargent, Michael Leszko, Erin Buysman, Sara Alvarez, Tyler J. Dunn, Josh Noone, Mico Guevarra
Summary: Patients with T2DM experienced significant reductions in HbA1c within 6 months following initiation of oral semaglutide. Patients with higher starting HbA1c levels experienced greater reductions. However, the initial dose of oral semaglutide was higher than prescribing instructions for more than half of the patients in the study.
ADVANCES IN THERAPY
(2023)
Article
Endocrinology & Metabolism
Louis Jacob, Sarah Rickwood, Wolfgang Rathmann, Karel Kostev
Summary: This study aimed to estimate the proportion of individuals with type 2 diabetes undergoing changes in glucose-lowering therapy in 2019 and 2020 in Germany. The results showed that the COVID-19 pandemic had a significant impact on the use of glucose-lowering drugs in T2DM patients, warranting further research to investigate the treatment and management of these individuals during the pandemic.
DIABETES OBESITY & METABOLISM
(2021)
Article
Medicine, General & Internal
Teresa A. Hillier, Kathryn L. Pedula, Keith K. Ogasawara, Kimberly K. Vesco, Caryn E. S. Oshiro, Suzanne L. Lubarsky, Jan Van Marter
Summary: In this study comparing one-step screening with two-step screening for gestational diabetes mellitus, the one-step approach resulted in more diagnoses of gestational diabetes mellitus but did not have a significant impact on the incidence of adverse perinatal and maternal outcomes.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Pharmacology & Pharmacy
Norazida Ab Rahman, Ming Tsuey Lim, Shantini Thevendran, Najwa Ahmad Hamdi, Sheamini Sivasampu
Summary: This study assessed medication burden, regimen complexity, and adherence among T2DM patients and found that high medication count and regimen complexity were associated with poor glycemic control, while adherence was inversely associated with HbA1c level. These parameters can be used to identify patients with complex pharmacotherapy regimens for targeted interventions to achieve optimum outcomes and ease of self-care.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Nutrition & Dietetics
Jing Ouyang, Yuwei Lai, Linjing Wu, Yi Wang, Ping Wu, Yi-Xiang Ye, Xue Yang, Yanyu Gao, Jiaying Yuan, Xingyue Song, Shijiao Yan, Chuanzhu Lv, Yi-Xin Wang, Gang Liu, Yayi Hu, An Pan, Xiong-Fei Pan
Summary: This study investigated the association between weight change from age 18 to pregnancy and gestational diabetes mellitus (GDM) among Chinese pregnant women. The results showed that weight change was linearly associated with a higher risk of GDM, and excessive weight gain increased the risk even more. Maintaining weight stability, especially preventing excessive weight gain from early adulthood to pregnancy, could be a potential strategy to reduce GDM risk.
AMERICAN JOURNAL OF CLINICAL NUTRITION
(2023)
Article
Endocrinology & Metabolism
Yuanzhou Peng, Na Han, Tao Su, Shuang Zhou, Heling Bao, Yuelong Ji, Shusheng Luo, Jue Liu, Hai-Jun Wang
Summary: This study investigated trajectories of gestational weight gain before diagnosis and its association with gestational diabetes mellitus (GDM) risk. Two trajectories of weight gain were identified, with women showing excessive weight gain having a significantly increased risk of developing GDM. Excessive weight gain also led to higher risks of macrosomia and cesarean delivery.
DIABETES RESEARCH AND CLINICAL PRACTICE
(2021)
Review
Biochemistry & Molecular Biology
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, Luca Rinaldi, Livio Criscuolo, Anna Di Martino, Gaetana Albanese, Erica Vetrano, Christian Catalini, Celestino Sardu, Giovanni Docimo, Raffaele Marfella, Ferdinando Carlo Sasso
Summary: Being overweight and obesity have long been associated with impaired glucose metabolism and type 2 diabetes (T2D), but there is also a less frequent form of T2D in non-obese individuals, especially in developing countries and non-white ethnic minorities in high-income Western countries. The mechanisms linking obesity to T2D have been extensively studied, but the pathophysiology and risk factors of T2D in non-obese people are still under debate. Understanding these factors and developing individualized clinical management may help reduce the global burden of diabetes.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Medicine, General & Internal
Ashby F. Walker, Sian Graham, Louise Maple-Brown, Leonard E. Egede, Jennifer A. Campbell, Rebekah J. Walker, Alisha N. Wade, Jean Claude Mbanya, Judith A. Long, Chittaranjan Yajnik, Nihal Thomas, Osagie Ebekozien, Oriyomi Odugbesan, Linda A. Dimeglio, Shivani Agarwal
Summary: Diabetes is a serious chronic disease that disproportionately affects certain communities based on socioeconomic, gender, racial, and ethnic factors. This article emphasizes the need to address the broader social context and systems in order to achieve equity in diabetes care and outcomes on a global scale. It presents best practice approaches and action plans to target diabetes equity, and showcases international examples of addressing diabetes inequity within a larger social context.
Article
Endocrinology & Metabolism
Nicole Prinz, Anke Schwandt, Bernadette Borgert, Bettina Hartmann, Hans-Peter Kempe, Julia K. Mader, Sigrund Merger, Rosmarie Weber-Lauffer, Frank-Juergen Wosch, Reinhard W. Holl
Summary: In patients with type-2 diabetes, insulin initiation leads to different patterns of weight change: significant increase, slight increase, or decrease. Older and obese patients are more likely to experience weight loss after starting insulin, while poor glycemic control, higher insulin dose, and severe hypoglycemic events are associated with weight gain trajectory.
DIABETES TECHNOLOGY & THERAPEUTICS
(2021)
Article
Medicine, Research & Experimental
Hrishikesh P. Kale, Zaina P. Qureshi, Ruchit Shah, Rezaul Khandker, Marc Botteman, Weilin Meng, Ruth Benca
Summary: In this study, changes in healthcare resource use and costs before and after suvorexant initiation in insomnia patients were analyzed. The results showed that suvorexant treatment was associated with immediate and continued decreases in healthcare resource use and costs, particularly for patients with mental health comorbidities. Further research is needed to understand the impact of suvorexant initiation on direct medical costs and productivity losses in other real-world settings.
ADVANCES IN THERAPY
(2021)
Article
Endocrinology & Metabolism
Jinbo Hu, Yang Hu, Ellen Hertzmark, Chen Yuan, Gang Liu, Meir J. Stampfer, Eric B. Rimm, Frank B. Hu, Molin Wang, Qi Sun
Summary: This study found a significant association between substantial weight loss and increased mortality among newly diagnosed type 2 diabetes patients, which was abolished by improving lifestyle quality.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2022)
Article
Endocrinology & Metabolism
Caro Minschart, Astrid Lammertyn, Paul Van Crombrugge, Carolien Moyson, Johan Verhaeghe, Sofie Vandeginste, Hilde Verlaenen, Chris Vercammen, Toon Maes, Els Dufraimont, Nele Roggen, Christophe De Block, Yves Jacquemyn, Farah Mekahli, Katrien De Clippel, Annick Van Den Bruel, Anne Loccufier, Annouschka Laenen, Roland Devlieger, Chantal Mathieu, Katrien Benhalima
Summary: The level of gestational weight gain (GWG) during pregnancy is associated with adverse pregnancy outcomes in women with gestational diabetes (GDM) compared to women with normal glucose tolerance (NGT). Low GWG below recommended levels frequently occurs in GDM women without increased risk for adverse outcomes. Excessive GWG is associated with increased risk for neonatal hypoglycemia and worse metabolic profile postpartum in GDM women, and with higher rates of instrumental delivery and larger infants in NGT women.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2023)